136 related articles for article (PubMed ID: 28344964)
1. Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women.
Park BR; Park HN; Jung JB; Lee ES; Kim JS; Choi GY; Lee JJ; Lee IS
Obstet Gynecol Sci; 2017 Mar; 60(2):213-217. PubMed ID: 28344964
[TBL] [Abstract][Full Text] [Related]
2. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
Lin SQ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Zhou YZ; Wang ML; Zhu J; Chen SR; Su H; Yang CS; Wang SH; Zhang YZ; Dong XJ
Climacteric; 2011 Aug; 14(4):472-81. PubMed ID: 21469973
[TBL] [Abstract][Full Text] [Related]
3. One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.
Genazzani AR; Schmelter T; Schaefers M; Gerlinger C; Gude K
Climacteric; 2013 Aug; 16(4):490-8. PubMed ID: 23531117
[TBL] [Abstract][Full Text] [Related]
4. Drospirenone and estradiol: a new option for the postmenopausal woman.
Archer DF
Climacteric; 2007 Feb; 10 Suppl 1():3-10. PubMed ID: 17364592
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
Preston RA; Norris PM; Alonso AB; Ni P; Hanes V; Karara AH
Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
Lee BS; Kang BM; Yoon BK; Choi H; Park HM; Kim JG
Maturitas; 2007 Aug; 57(4):361-9. PubMed ID: 17467203
[TBL] [Abstract][Full Text] [Related]
7. Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate.
Junge W; El-Samalouti V; Gerlinger C; Schaefers M
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):195-200. PubMed ID: 19879683
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.
White WB; Hanes V; Chauhan V; Pitt B
Hypertension; 2006 Aug; 48(2):246-53. PubMed ID: 16801478
[TBL] [Abstract][Full Text] [Related]
9. Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.
Vitale C; Mammi C; Gambacciani M; Russo N; Spoletini I; Fini M; Volterrani M; Rosano GMC
Int J Cardiol; 2017 Jan; 227():217-221. PubMed ID: 27843051
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
White WB; Pitt B; Preston RA; Hanes V
Circulation; 2005 Sep; 112(13):1979-84. PubMed ID: 16186434
[TBL] [Abstract][Full Text] [Related]
12. Effects of continuous-combined oral drospirenone- estradiol on blood pressure, body weight & lipid profile in early menopausal women.
Đogo A; Dožić B; Vujović S; Srebro D; Dožić I
Indian J Med Res; 2021 Jun; 154(6):857-865. PubMed ID: 35662091
[TBL] [Abstract][Full Text] [Related]
13. Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism.
Palacios S; Foidart JM; Genazzani AR
Maturitas; 2006 Nov; 55(4):297-307. PubMed ID: 16949774
[TBL] [Abstract][Full Text] [Related]
14. Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
Preston RA; White WB; Pitt B; Bakris G; Norris PM; Hanes V
Am J Hypertens; 2005 Jun; 18(6):797-804. PubMed ID: 15925739
[TBL] [Abstract][Full Text] [Related]
15. Effects of drospirenone and norethisterone acetate combined with estradiol on mammographic density and proliferation of breast epithelial cells-A prospective randomized trial.
Hirschberg AL; Tani E; Brismar K; Lundström E
Maturitas; 2019 Aug; 126():18-24. PubMed ID: 31239112
[TBL] [Abstract][Full Text] [Related]
16. Effects of hormone therapy containing 2 mg drospirenone and 1 mg 17β-estradiol on postmenopausal exacerbation of Meniere's disease: Preliminary study.
Grillo CM; Maiolino L; Rapisarda AMC; Caruso G; Palermo G; Caruso S
Exp Ther Med; 2021 Oct; 22(4):1103. PubMed ID: 34504557
[TBL] [Abstract][Full Text] [Related]
17. Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril.
Preston RA; Alonso A; Panzitta D; Zhang P; Karara AH
Am J Hypertens; 2002 Sep; 15(9):816-22. PubMed ID: 12219878
[TBL] [Abstract][Full Text] [Related]
18. Effects of the hormone therapy, drospirenone and 17-beta estradiol, on early morning blood pressure in postmenopausal women with hypertension.
White WB; Hanes V; Mallareddy M; Chauhan V
J Am Soc Hypertens; 2008; 2(1):20-7. PubMed ID: 20409881
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
Karara AH; Hanes V; Alonso A; Ni P; Poola N; Silang R; Blode H; Preston RA
J Clin Pharmacol; 2007 Oct; 47(10):1292-302. PubMed ID: 17906162
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
Archer DF; Thorneycroft IH; Foegh M; Hanes V; Glant MD; Bitterman P; Kempson RL
Menopause; 2005; 12(6):716-27. PubMed ID: 16278615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]